Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.05B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.61B |
| 3 |
Tesla
TSLA
|
+$636M |
| 4 |
TSMC
TSM
|
+$604M |
| 5 |
iShares Bitcoin Trust
IBIT
|
+$330M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.25B |
| 2 |
Apple
AAPL
|
+$1.13B |
| 3 |
Microsoft
MSFT
|
+$988M |
| 4 |
Meta Platforms (Facebook)
META
|
+$572M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$570M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 1.55% |
| 2 | Consumer Discretionary | 0.95% |
| 3 | Financials | 0.77% |
| 4 | Healthcare | 0.67% |
| 5 | Industrials | 0.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLYM
11851
Climb Bio
CLYM
$951M
| $51.9K | ﹤0.01% |
42,506
+28,260
| +198% | +$45.8K |
|
|
BZAI
11852
Blaize Holdings
BZAI
$72.5M
| $51.7K | ﹤0.01% |
+25,584
| New | +$116K |
|
11853
CALL
Conduent
CNDT
$257M
| $51.6K | ﹤0.01% |
19,100
-5,800
| -23% | -$21.2K |
|
11854
Sadot Group
SDOT
$25M
| $51.1K | ﹤0.01% |
95
+44
| +86% | +$27.5K |
|
11855
Intelligent Bio Solutions
INBS
$6.81M
| $51.1K | ﹤0.01% |
+3,549
| New | +$66.2K |
|
|
CAN
11856
Canaan Creative
CAN
$293M
| $51.1K | ﹤0.01% |
58,191
-462,951
| -89% | -$736K |
|
|
RAPT
11857
DELISTED
RAPT Therapeutics
RAPT
| $50.8K | ﹤0.01% |
5,207
+1,515
| +41% | +$14.9K |
|
|
SVCO
11858
Silvaco Group
SVCO
$233M
| $50.7K | ﹤0.01% |
+11,116
| New | +$76K |
|
|
LNAI
11859
CALL
Lunai Bioworks
LNAI
$10.9M
| $50.4K | ﹤0.01% |
1,168
+704
| +152% | +$45.1K |
|
11860
Xtant Medical Holdings
XTNT
$45M
| $50.3K | ﹤0.01% |
107,123
-77,566
| -42% | -$40.8K |
|
11861
CALL
Toro Corp
TORO
$220M
| $50K | ﹤0.01% |
+20,400
| New | +$55.9K |
|
11862
PUT
GSI Technology
GSIT
$225M
| $49.9K | ﹤0.01% |
24,600
+6,000
| +32% | +$17.5K |
|
|
GPMT
11863
PUT
Granite Point Mortgage Trust
GPMT
$50.1M
| $49.9K | ﹤0.01% |
19,200
-1,300
| -6% | -$3.7K |
|
|
OPI
11864
DELISTED
Office Properties Income Trust
OPI
| $49.7K | ﹤0.01% |
109,015
-264,496
| -71% | -$226K |
|
11865
Milestone Pharmaceuticals
MIST
$143M
| $49.7K | ﹤0.01% |
62,060
+28,968
| +88% | +$57.6K |
|
11866
PUT
AtaiBeckley Inc
ATAI
$2.75B
| $49.6K | ﹤0.01% |
36,500
+8,900
| +32% | +$15K |
|
11867
PUT
Hycroft Mining Holding Corp
HYMC
$2.36B
| $49.6K | ﹤0.01% |
15,300
-145,100
| -90% | -$373K |
|
11868
Mobile Infrastructure Corp
BEEP
$124M
| $49.5K | ﹤0.01% |
+11,879
| New | +$45.8K |
|
|
SLRN
11869
CALL
DELISTED
ACELYRIN
SLRN
| $49.4K | ﹤0.01% |
+20,000
| New | +$47.6K |
|
11870
CALL
Phunware
PHUN
$43M
| $49.3K | ﹤0.01% |
16,700
-19,800
| -54% | -$76K |
|
11871
Beam Global
BEEM
$38.6M
| $49.2K | ﹤0.01% |
24,114
-72,116
| -75% | -$186K |
|
11872
PUT
Zentalis Pharmaceuticals
ZNTL
$369M
| $49.1K | ﹤0.01% |
30,900
+16,100
| +109% | +$34.7K |
|
|
VXRT
11873
DELISTED
Vaxart
VXRT
| $49.1K | ﹤0.01% |
120,702
-208,095
| -63% | -$133K |
|
11874
Shattuck Labs
STTK
$794M
| $48.9K | ﹤0.01% |
51,438
+14,986
| +41% | +$18.5K |
|
11875
CALL
Bionano Genomics
BNGO
$14.6M
| $48.8K | ﹤0.01% |
+17,500
| New | +$115K |
|
Similar funds
Jeff Yass's Q1 2025 Portfolio in Review
As of Q1 2025, Jeff Yass held 13,842 positions worth $586B, down 12% from $663B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jeff Yass withdrew a net $24.4B in Q1 2025, closing 1,482 positions and reducing 4,842 holdings. Its most notable exit was Inari Medical, Inc. Common Stock, an estimated $24M position sold in full.
By sector, the portfolio is most concentrated in Technology at 1.6% of assets, down from 2% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Jeff Yass opened a new position in Brookfield Asset Management worth $86M.
- Jeff Yass's largest Q1 2025 buy was Brookfield Asset Management: 1,775,684 shares worth $86M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $4.05B increase.
- Jeff Yass's biggest Q1 2025 reduction was Invesco QQQ Trust, cutting an estimated $1.25B.
- Jeff Yass fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $24M.
- Jeff Yass's ten largest holdings make up 28% of its $586B portfolio in Q1 2025.
- Jeff Yass opened 1,775 new positions and closed 1,482 in Q1 2025.
- Jeff Yass's portfolio value fell 12% quarter-over-quarter to $586B.
Based on Susquehanna International Group's 13F filing for Q1 2025, filed 14 May 2025.